Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Checler, F' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 75 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Petit, A; Bihel, F; da Costa, CA; Pourquie, O; Checler, F; Kraus, JL
      New protease inhibitors prevent gamma-secretase-mediated production of A beta 40/42 without affecting Notch cleavage

      NATURE CELL BIOLOGY
    2. Armogida, M; Petit, A; Vincent, B; Scarzello, S; da Costa, CA; Checler, F
      Endogenous beta-amyloid production in presenilin-deficient embryonic mousefibroblasts

      NATURE CELL BIOLOGY
    3. De Jonghe, C; Esselens, C; Kumar-Singh, S; Craessaerts, K; Serneels, S; Checler, F; Annaert, W; Van Broeckhoven, C; De Strooper, B
      Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect A beta secretion and APP C-terminal fragment stability

      HUMAN MOLECULAR GENETICS
    4. Hasebe, T; Hua, J; Someya, A; Morain, P; Checler, F; Nagaoka, I
      Involvement of cytosolic prolyl endopeptidase in degradation of p40-phox splice variant protein in myeloid cells

      JOURNAL OF LEUKOCYTE BIOLOGY
    5. Dumanchin-Njock, C; da Costa, CA; Mercken, L; Pradier, L; Checler, F
      The caspase-derived C-terminal fragment of beta APP induces caspase-independent toxicity and triggers selective increase of A beta 42 in mammalian cells

      JOURNAL OF NEUROCHEMISTRY
    6. Checler, F
      The multiple paradoxes of presenilins

      JOURNAL OF NEUROCHEMISTRY
    7. Lopez-Perez, E; Zhang, Y; Frank, SJ; Creemers, J; Seidah, N; Checler, F
      Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10

      JOURNAL OF NEUROCHEMISTRY
    8. Vincent, B; Paitel, E; Saftig, P; Frobert, Y; Hartmann, D; De Strooper, B; Grassi, J; Lopez-Perez, E; Checler, F
      The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein

      JOURNAL OF BIOLOGICAL CHEMISTRY
    9. Benjannet, S; Elagoz, A; Wickham, L; Mamarbachi, M; Munzer, JS; Basak, A; Lazure, C; Cromlish, JA; Sisodia, S; Checler, F; Chretien, M; Seidah, NG
      Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding - The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production

      JOURNAL OF BIOLOGICAL CHEMISTRY
    10. Nunan, J; Shearman, MS; Checler, F; Cappai, R; Evin, G; Beyreuther, K; Masters, CL; Small, DH
      The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    11. Mestre-Frances, N; Keller, E; Calenda, A; Barelli, H; Checler, F; Bons, N
      Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcebus murinus reveal distinct amyloid beta 1-42 and beta 1-40 immunoreactivity profiles

      NEUROBIOLOGY OF DISEASE
    12. Kumar-Singh, S; Dewachter, I; Moechars, D; Lubke, U; De Jonghe, C; Ceuterick, C; Checler, F; Naidu, A; Cordell, B; Cras, P; Van Broeckhoven, C; Van Leuven, F
      Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation

      NEUROBIOLOGY OF DISEASE
    13. Checler, F; da Costa, CA; Ancolio, K; Chevallier, N; Lopez-Perez, E; Marambaud, P
      Role of the proteasome in Alzheimer's disease

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
    14. Colle, MA; Duyckaerts, C; Laquerriere, A; Pradier, L; Czech, C; Checler, F; Hauw, JJ
      Laminar specific loss of isocortical presenilin 1 immunoreactivity in Alzheimer's disease. Correlations with the amyloid load and the density of tau-positive neurofibrillary tangles

      NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    15. Ancolio, K; da Costa, CA; Ueda, K; Checler, F
      alpha-Synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells

      NEUROSCIENCE LETTERS
    16. Colle, MA; Hauw, JJ; Crespeau, F; Uchihara, T; Akiyama, H; Checler, F; Pageat, P; Duykaerts, C
      Vascular and parenchymal A beta deposition in the aging dog: correlation with behavior

      NEUROBIOLOGY OF AGING
    17. Amson, R; Lassalle, JM; Halley, H; Prieur, S; Lethrosne, F; Roperch, JP; Israeli, D; Gendron, MC; Duyckaerts, C; Checler, F; Dausset, J; Cohen, D; Oren, M; Telerman, A
      Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    18. Petanceska, SS; Seeger, M; Checler, F; Gandy, S
      Mutant presenilin 1 increases the levels of Alzheimer amyloid beta-peptideA beta 42 in late compartments of the constitutive secretory pathway

      JOURNAL OF NEUROCHEMISTRY
    19. Vincent, B; Paitel, E; Frobert, Y; Lehmann, S; Grassi, J; Checler, F
      Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons

      JOURNAL OF BIOLOGICAL CHEMISTRY
    20. da Costa, CA; Ancolio, K; Checler, F
      Wild-type but not Parkinson's disease-related Ala-53 -> Thr mutant alpha-synuclein protects neuronal cells from apoptotic stimuli

      JOURNAL OF BIOLOGICAL CHEMISTRY
    21. Petit, A; Barelli, H; Morain, P; Checler, F
      Novel proline endopeptidase inhibitors do not modify A beta 40/42 formation and degradation by human cells expressing wild-type and Swedish mutated beta-amyloid precursor protein

      BRITISH JOURNAL OF PHARMACOLOGY
    22. Lopez-Perez, E; Dumanchin, C; Czech, C; Campion, D; Goud, B; Pradier, L; Frebourg, T; Checler, F
      Overexpression of Rab11 or constitutively active Rab11 does not affect sAPP alpha and A beta secretions by wild-type and Swedish mutated beta APP-expressing HEK293 cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    23. Van Dorpe, J; Smeijers, L; Dewachter, I; Nuyens, D; Spittaels, K; Van den Haute, C; Mercken, M; Moechars, D; Laenen, I; Kuiperi, C; Bruynseels, K; Tesseur, I; Loos, R; Vanderstichele, H; Checler, F; Sciot, R; Van Leuven, F
      Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons

      AMERICAN JOURNAL OF PATHOLOGY
    24. Gouras, GK; Tsai, J; Naslund, J; Vincent, B; Edgar, M; Checler, F; Greenfield, JP; Haroutunian, V; Buxbaum, JD; Xu, HX; Greengard, P; Relkin, NR
      Intraneuronal A beta 42 accumulation in human brain

      AMERICAN JOURNAL OF PATHOLOGY
    25. Checler, F
      Presenilins: Multifunctional proteins involved in Alzheimer's disease pathology

      IUBMB LIFE
    26. Chui, DH; Tanahashi, H; Ozawa, K; Ikeda, S; Checler, F; Ueda, O; Suzuki, H; Araki, W; Inoue, H; Shirotani, K; Takahashi, K; Gallyas, F; Tabira, T
      Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation

      NATURE MEDICINE
    27. da Costa, CA; Ancolio, K; Checler, F
      C-terminal maturation fragments of presenilin 1 and 2 control secretion ofAPP alpha and A beta by human cells and are degraded by proteasome

      MOLECULAR MEDICINE
    28. Garrido, PAG; Vandenbulcke, F; Ramjaun, AR; Vincent, B; Checler, F; Ferro, E; Beaudet, A
      Confocal microscopy reveals thimet oligopeptidase (EC 3.4.24.15) and neurolysin (EC 3.4.24.16) in the classical secretory pathway

      DNA AND CELL BIOLOGY
    29. Checler, F
      Presenilins - Structural aspects and posttranslational events

      MOLECULAR NEUROBIOLOGY
    30. Checler, F
      The mystery of presenilins. The research winner by KO?

      COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES
    31. Ancolio, K; Dumanchin, C; Barelli, H; Warter, JM; Brice, A; Campion, D; Frebourg, T; Checler, F
      Unusual phenotypic alteration of beta amyloid precursor protein (beta APP)maturation by a new Val-715 -> Met beta APP-770 mutation responsible for probable early-onset Alzheimer's disease

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    32. Herreman, A; Hartmann, D; Annaert, W; Saftig, P; Craessaerts, K; Serneels, L; Umans, L; Schrijvers, V; Checler, F; Vanderstichele, H; Baekelandt, V; Dressel, R; Cupers, P; Huylebroeck, D; Zwijsen, A; Van Leuven, F; De Strooper, B
      Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    33. Greenfield, JP; Tsai, J; Gouras, GK; Hai, B; Thinakaran, G; Checler, F; Sisodia, SS; Greengard, P; Xu, HX
      Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    34. Lopez-Perez, E; Seidah, NG; Checler, F
      Proprotein convertase activity contributes to the processing of the Alzheimer's beta-amyloid precursor protein in human cells: Evidence for a role ofthe prohormone convertase PC7 in the constitutive alpha-secretase pathway

      JOURNAL OF NEUROCHEMISTRY
    35. Moechars, D; Dewachter, I; Lorent, K; Reverse, D; Baekelandt, V; Naidu, A; Tesseur, I; Spittaels, K; Van Den Haute, C; Checler, F; Godaux, E; Cordell, B; Van Leuven, F
      Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

      JOURNAL OF BIOLOGICAL CHEMISTRY
    36. Marambaud, P; Ancolio, K; da Costa, CA; Checler, F
      Effect of protein kinase A inhibitors on the production of A beta 40 and Abeta 42 by human cells expressing normal and Alzheimer's disease-linked mutated beta APP and presenilin 1

      BRITISH JOURNAL OF PHARMACOLOGY
    37. Barelli, H; Petit, A; Hirsch, E; Wilk, S; De Nanteuil, G; Morain, P; Checler, F
      S17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    38. XU HX; GOURAS GK; GREENFIELD JP; VINCENT B; NASLUND J; MAZZARELLI L; FRIED G; JOVANOVIC JN; SEEGER M; RELKIN NR; LIAO F; CHECLER F; BUXBAUM JD; CHAIT BT; THINAKARAN G; SISODIA SS; WANG R; GREENGARD P; GANDY S
      ESTROGEN REDUCES NEURONAL GENERATION OF ALZHEIMER BETA-AMYLOID PEPTIDES

      Nature medicine
    39. MARAMBAUD P; ANCOLIO K; LOPEZPEREZ E; CHECLER F
      PROTEASOME INHIBITORS PREVENT THE DEGRADATION OF FAMILIAL ALZHEIMERS-DISEASE-LINKED PRESENILIN-1 AND POTENTIATE A-BETA-42 RECOVERY FROM HUMAN-CELLS

      Molecular medicine
    40. Marambaud, P; Chevallier, N; Ancolio, K; Checler, F
      Post-transcriptional contribution of a cAMP-dependent pathway to the formation of alpha- and beta/gamma-secretases-derived products of beta APP maturation in human cells expressing wildtype and Swedish mutated beta APP

      MOLECULAR MEDICINE
    41. TRONCOSO JC; CATALDO AM; NIXON RA; BARNETT JL; LEE MK; CHECLER F; FOWLER DR; SMIALEK JE; CRAIN B; MARTIN LJ; KAWAS CH
      NEUROPATHOLOGY OF PRECLINICAL AND CLINICAL LATE-ONSET ALZHEIMERS-DISEASE

      Annals of neurology
    42. MARAMBAUD P; DACOSTA CA; ANCOLIO K; CHECLER F
      ALZHEIMERS-DISEASE-LINKED MUTATION OF PRESENILIN-2 (N1411-PS2) DRASTICALLY LOWERS APP-ALPHA SECRETION - CONTROL BY THE PROTEASOME

      Biochemical and biophysical research communications (Print)
    43. RIOLI V; KATO A; PORTARO FCV; CURY GK; TEKAAT K; VINCENT B; CHECLER F; CAMARGO ACM; GLUCKSMAN MJ; ROBERTS JL; HIROSE S; FERRO ES
      NEUROPEPTIDE SPECIFICITY AND INHIBITION OF RECOMBINANT ISOFORMS OF THE ENDOPEPTIDASE-3.4.24.16 FAMILY - COMPARISON WITH THE RELATED RECOMBINANT ENDOPEPTIDASE-3.4.24.15

      Biochemical and biophysical research communications (Print)
    44. BARELLI HL; LEBEAU A; VIZZAVONA J; DELAERE P; CHEVALLIER N; DROUOT C; MARAMBAUD P; ANCOLIO K; BUXBAUM JD; KHORKOVA O; HEROUX J; SAHASRABUDHE S; MARTINEZ J; WARTER JM; MOHR M; CHECLER F
      CHARACTERIZATION OF NEW POLYCLONAL ANTIBODIES SPECIFIC FOR 40 AND 42 AMINO-ACID LONG AMYLOID-BETA PEPTIDES - THEIR USE TO EXAMINE THE CELL BIOLOGY OF PRESENILINS AND THE IMMUNOHISTOCHEMISTRY OF SPORADIC ALZHEIMERS-DISEASE AND CEREBRAL AMYLOID ANGIOPATHY CASES

      Molecular medicine
    45. MOHR M; TRAIICHANT C; CHECLER F; WARTER JM
      SPORADIC CEREBRAL AMYLOID ANGIOPATHY PRESENTING AS FRONTAL DEMENTIA -A CASE WITH UNUSUAL HISTOLOGICAL FEATURES

      Brain pathology
    46. DAUCH P; CHAMPIGNY G; RICCI JE; CHECLER F
      LACK OF EFFECT OF PRESENILIN-1, BETA-APP AND THEIR ALZHEIMERS DISEASE-RELATED MUTATED FORMS ON XENOPUS OOCYTES MEMBRANE CURRENTS

      Neuroscience letters
    47. ANCOLIO K; MARAMBAUD P; DAUCH P; CHECLER F
      ALPHA-SECRETASE-DERIVED PRODUCT OF BETA-AMYLOID PRECURSOR PROTEIN IS DECREASED BY PRESENILIN-1 MUTATIONS LINKED TO FAMILIAL ALZHEIMERS-DISEASE

      Journal of neurochemistry
    48. MARAMBAUD P; LOPEZPEREZ E; WILK S; CHECLER F
      CONSTITUTIVE AND PROTEIN-KINASE C-REGULATED SECRETORY CLEAVAGE OF ALZHEIMERS BETA-AMYLOID PRECURSOR PROTEIN - DIFFERENT CONTROL OF EARLY AND LATE EVENTS BY THE PROTEASOME

      Journal of neurochemistry
    49. MARAMBAUD P; CHEVALLIER N; BARELLI H; WILK S; CHECLER F
      PROTEASOME CONTRIBUTES TO THE ALPHA-SECRETASE PATHWAY OF AMYLOID PRECURSOR PROTEIN IN HUMAN-CELLS

      Journal of neurochemistry
    50. VINCENT B; DAUCH P; VINCENT JP; CHECLER F
      STABLY TRANSFECTED HUMAN-CELLS OVEREXPRESSING RAT-BRAIN ENDOPEPTIDASE-3.4.24.16 - BIOCHEMICAL-CHARACTERIZATION OF THE ACTIVITY AND EXPRESSION OF SOLUBLE AND MEMBRANE-ASSOCIATED COUNTERPARTS

      Journal of neurochemistry
    51. VINCENT B; JIRACEK J; NOBLE F; LOOG M; ROQUES B; DIVE V; VINCENT JP; CHECLER F
      CONTRIBUTION OF ENDOPEPTIDASE 3.4.24.15 TO CENTRAL NEUROTENSIN INACTIVATION

      European journal of pharmacology
    52. VINCENT B; JIRACEK J; NOBLE F; LOOG M; ROQUES B; DIVE V; VINCENT JP; CHECLER F
      EFFECT OF A NOVEL SELECTIVE AND POTENT PHOSPHINIC PEPTIDE INHIBITOR OF ENDOPEPTIDASE-3.4.24.16 ON NEUROTENSIN-INDUCED ANALGESIA AND NEURONAL INACTIVATION

      British Journal of Pharmacology
    53. CHEVALLIER N; JIRACEK J; VINCENT B; BAUR CP; SPILLANTINI MG; GOEDERT M; DIVE V; CHECLER F
      EXAMINATION OF THE ROLE OF ENDOPEPTIDASE-3.4.24.15 IN A-BETA SECRETION BY HUMAN TRANSFECTED CELLS

      British Journal of Pharmacology
    54. CHEVALLIER N; VIZZAVONA J; MARAMBAUD P; BAUR CP; SPILLANTINI M; FULCRAND P; MARTINEZ J; GOEDERT M; VINCENT JP; CHECLER F
      CATHEPSIN-D DISPLAYS IN-VITRO BETA-SECRETASE-LIKE SPECIFICITY

      Brain research
    55. VINCENT B; BEAUDET A; DAUCH P; VINCENT JP; CHECLER F
      DISTINCT PROPERTIES OF NEURONAL AND ASTROCYTIC ENDOPEPTIDASE-3.4.24.16 - A STUDY ON DIFFERENTIATION, SUBCELLULAR-DISTRIBUTION, AND SECRETION PROCESSES

      The Journal of neuroscience
    56. MARAMBAUD P; WILK S; CHECLER F
      PROTEIN-KINASE-A PHOSPHORYLATION OF THE PROTEASOME - A CONTRIBUTION TO THE ALPHA-SECRETASE PATHWAY IN HUMAN-CELLS

      Journal of neurochemistry
    57. JIRACEK J; YIOTAKIS A; VINCENT B; CHECLER F; DIVE V
      DEVELOPMENT OF THE FIRST POTENT AND SELECTIVE INHIBITOR OF THE ZINC ENDOPEPTIDASE NEUROLYSIN USING A SYSTEMATIC-APPROACH BASED ON COMBINATORIAL CHEMISTRY OF PHOSPHINIC PEPTIDES

      The Journal of biological chemistry
    58. VINCENT B; VINCENT JP; CHECLER F
      PURIFICATION AND CHARACTERIZATION OF HUMAN ENDOPEPTIDASE-3.4.24.16 - COMPARISON WITH THE PORCINE COUNTERPART INDICATES A UNIQUE CLEAVAGE SITE ON NEUROTENSIN

      Brain research
    59. BARELLI H; WOSKOWSKA Z; CIPRIS S; FOXTHRELKELD JET; DANIEL EE; VINCENT JP; CHECLER F
      PHARMACOLOGICAL ROLE AND DEGRADATION PROCESSES OF NEUROMEDIN-N IN THEGASTROINTESTINAL-TRACT - AN IN-VITRO AND IN-VIVO STUDY

      The Journal of pharmacology and experimental therapeutics
    60. CHECLER F
      PROCESSING OF THE BETA-AMYLOID PRECURSOR PROTEIN AND ITS REGULATION IN ALZHEIMERS-DISEASE

      Journal of neurochemistry
    61. CHECLER F; VINCENT JP
      STUDY ON THE ESTERASE, ARYLACYLAMIDASE AND PEPTIDASE ACTIVITIES OF ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE

      Journal of neurochemistry
    62. DAUCH P; VINCENT JP; CHECLER F
      MOLECULAR-CLONING AND EXPRESSION OF RAT-BRAIN ENDOPEPTIDASE-3.4.24.16

      The Journal of biological chemistry
    63. JIRACEK J; YIOTAKIS A; VINCENT B; LECOQ A; NICOLAOU A; CHECLER F; DIVE V
      DEVELOPMENT OF HIGHLY POTENT AND SELECTIVE PHOSPHINIC PEPTIDE INHIBITORS OF ZINC ENDOPEPTIDASE-24-15 USING COMBINATORIAL CHEMISTRY

      The Journal of biological chemistry
    64. VINCENT B; DIVE V; YIOTAKIS A; SMADJA C; MALDONADO R; VINCENT JP; CHECLER F
      PHOSPHORUS-CONTAINING PEPTIDES AS MIXED INHIBITORS OF ENDOPEPTIDASE-3.4.24.15 AND ENDOPEPTIDASE-3.4.24.16 - EFFECT ON NEUROTENSIN DEGRADATION IN-VITRO AND IN-VIVO

      British Journal of Pharmacology
    65. CHECLER F; ICHAI C; CHEVALLIER N; DELAERE P; DOURNAUD P; EPELBAUM J; HAUW JJ; VINCENT JP
      NEUROPEPTIDASES AND PEPTIDES CATABOLISM IN ALZHEIMERS-DISEASE

      Neurobiology of aging
    66. CHECLER F; BARELLI H; BEAUDET A; DAUCH P; DIVE V; VINCENT B; VINCENT JP
      RECENT ADVANCES ON ENDOPEPTIDASE-3.4.24.16

      Journal of neurochemistry
    67. ICHAI C; CHEVALLIER N; DELAERE P; DOURNAUD P; EPELBAUM J; HAUW JJ; VINCENT JP; CHECLER F
      INFLUENCE OF REGION-SPECIFIC ALTERATIONS OF NEUROPEPTIDASE CONTENT ONTHE CATABOLIC FATES OF NEUROPEPTIDES IN ALZHEIMERS-DISEASE

      Journal of neurochemistry
    68. CHECLER F; GRASSI J; VINCENT JP
      CHOLINESTERASES DISPLAY GENUINE ARYLACYLAMIDASE ACTIVITY BUT ARE TOTALLY DEVOID OF INTRINSIC PEPTIDASE ACTIVITIES

      Journal of neurochemistry
    69. VINCENT B; VINCENT JP; CHECLER F
      NEUROTENSIN AND NEUROMEDIN-N UNDERGO DISTINCT CATABOLIC PROCESSES IN MURINE ASTROCYTES AND PRIMARY CULTURED NEURONS

      European journal of biochemistry
    70. BARELLI H; FOXTHRELKELD JET; DIVE V; DANIEL EE; VINCENT JP; CHECLER F
      ROLE OF ENDOPEPTIDASE-3.4.24.16 IN THE CATABOLISM OF NEUROTENSIN, IN-VIVO, IN THE VASCULARLY PERFUSED DOG ILEUM

      British Journal of Pharmacology
    71. CHECLER F; BARELLI H; DAUCH P; VINCENT B; DIVE V; BEAUDET A; DANIEL EE; FOXTHRELKELD JET; MASUO Y; VINCENT JP
      RECENT ADVANCES ON ENDOPEPTIDASE-3.4.24.16

      Biochemical Society transactions
    72. BARELLI H; MAO YK; VINCENT B; DANIEL EE; VINCENT JP; CHECLER F
      DIFFERENTIAL CATABOLIC FATE OF NEUROMEDIN-N AND NEUROTENSIN IN THE CANINE INTESTINAL-MUCOSA

      Peptides
    73. DAUCH P; MASUO Y; VINCENT JP; CHECLER F
      A SURVEY OF THE CEREBRAL REGIONALIZATION AND ONTOGENY OF 8 EXOPEPTIDASES AND ENDOPEPTIDASES IN MURINES

      Peptides
    74. ICHAI C; CHEVALLIER N; DELAERE P; DOURNAUD P; EPELBAUM J; HAUW JJ; VINCENT JP; CHECLER F
      NEUROPEPTIDASES IN CORTICAL AREAS AND IN THE CEREBELLUM IN ALZHEIMERS-DISEASE - REGION-SPECIFIC ALTERATIONS LEAD TO MODIFIED CATABOLIC FATEOF SOMATOSTATIN(1-14)

      Journal of neurochemistry
    75. DOULUT S; DUBUC I; RODRIGUEZ M; VECCHINI F; FULCRAND H; BARELLI H; CHECLER F; BOURDEL E; AUMELAS A; LALLEMENT JC; KITABGI P; COSTENTIN J; MARTINEZ J
      SYNTHESIS AND ANALGESIC EFFECTS OF L]-1-OXO-2(R)-BENZYLPROPYL]-L-ISOLEUCYL-L-LEUCINE, A NEW POTENT INHIBITOR OF MULTIPLE NEUROTENSIN NEUROMEDIN-N DEGRADING ENZYMES

      Journal of medicinal chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/02/20 alle ore 23:55:29